Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation
Crossref DOI link: https://doi.org/10.1007/s10157-016-1321-5
Published Online: 2016-08-17
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takahashi, Kota
,
Saito, Kazuhide
Takahara, Shiro
Fuchinoue, Shohei
Yagisawa, Takashi
Aikawa, Atsushi
Watarai, Yoshihiko
Yoshimura, Norio
Tanabe, Kazunari
Morozumi, Kunio
Shimazu, Motohide
License valid from 2016-08-17